Two Sigma Investments, LP Lexicon Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 204,879 shares of LXRX stock, worth $145,464. This represents 0.0% of its overall portfolio holdings.

Number of Shares

204,879

Previous 19,156 969.53%

Holding current value

$145,464

Previous $32,000 903.13%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.51 - $2.39 $280,441 - $443,877	185,723 Added 969.53%	204,879 $321,000
Q2 2024 Aug 14, 2024	SELL	$1.54 - $2.28 $262,223 - $388,226	-170,275 Reduced 89.89%	19,156 $32,000
Q1 2024 May 15, 2024	SELL	$1.3 - $3.58 $17,492 - $48,172	-13,456 Reduced 6.63%	189,431 $454,000
Q4 2023 Feb 14, 2024	SELL	$1.0 - $1.53 $442,481 - $676,995	-442,481 Reduced 68.56%	202,887 $310,000
Q3 2023 Nov 14, 2023	BUY	$1.06 - $2.33 $548,789 - $1.21 Million	517,726 Added 405.61%	645,368 $703,000
Q2 2023 Aug 14, 2023	BUY	$2.15 - $3.49 $274,430 - $445,470	127,642 New	127,642 $292,000
Q4 2022 Feb 14, 2023	BUY	$1.8 - $2.56 $129,481 - $184,151	71,934 Added 166.14%	115,231 $220,000
Q3 2022 Nov 14, 2022	BUY	$1.94 - $3.43 $83,996 - $148,508	43,297 New	43,297 $104,000
Q3 2021 Nov 15, 2021	SELL	$3.38 - $5.35 $989,988 - $1.57 Million	-292,896 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$4.12 - $5.87 $731,061 - $1.04 Million	-177,442 Reduced 37.73%	292,896 $1.34 Million
Q1 2021 May 17, 2021	BUY	$3.45 - $9.09 $1.62 Million - $4.28 Million	470,338 New	470,338 $2.76 Million
Q3 2020 Nov 16, 2020	SELL	$1.44 - $2.1 $279,443 - $407,521	-194,058 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$1.75 - $2.3 $311,778 - $409,765	-178,159 Reduced 47.86%	194,058 $387,000
Q1 2020 May 15, 2020	SELL	$1.8 - $4.28 $1.11 Million - $2.65 Million	-618,202 Reduced 62.42%	372,217 $726,000
Q4 2019 Feb 14, 2020	BUY	$3.16 - $5.15 $2.74 Million - $4.46 Million	866,040 Added 696.29%	990,419 $4.11 Million
Q3 2019 Nov 14, 2019	BUY	$1.2 - $6.66 $12,886 - $71,521	10,739 Added 9.45%	124,379 $374,000
Q2 2019 Aug 14, 2019	SELL	$5.35 - $7.11 $8,196 - $10,892	-1,532 Reduced 1.33%	113,640 $715,000
Q1 2019 May 15, 2019	SELL	$4.36 - $7.94 $866,353 - $1.58 Million	-198,705 Reduced 63.31%	115,172 $640,000
Q4 2018 Feb 14, 2019	BUY	$6.15 - $10.51 $794,672 - $1.36 Million	129,215 Added 69.97%	313,877 $2.08 Million
Q3 2018 Nov 14, 2018	SELL	$10.32 - $13.06 $791,244 - $1 Million	-76,671 Reduced 29.34%	184,662 $1.97 Million
Q2 2018 Aug 14, 2018	BUY	$7.8 - $13.69 $605,748 - $1.06 Million	77,660 Added 42.28%	261,333 $3.14 Million
Q1 2018 May 15, 2018	BUY	$7.86 - $11.39 $58,572 - $84,878	7,452 Added 4.23%	183,673 $1.57 Million
Q4 2017 Feb 14, 2018	BUY	$8.77 - $12.28 $558,403 - $781,892	63,672 Added 56.57%	176,221 $1.74 Million
Q3 2017 Nov 14, 2017	BUY	$12.17 - $16.3 $1.37 Million - $1.83 Million	112,549	112,549 $1.38 Million

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $134M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Lexicon Pharmaceuticals, Inc. Transaction History